VCV002894197.1 - ClinVar

NM_000501.4(ELN):c.1034_1087dup (p.Ala362_Ala363insGlyValProGlyAlaGlyIleProValValProGlyAlaGlyIleProGlyAla)

Germline

Classification

The aggregate germline classification for this variant, typically for a monogenic or Mendelian disorder as in the ACMG/AMP guidelines, or for response to a drug. This value is calculated by NCBI based on data from submitters. Read our rules for calculating the aggregate classification.

(1)

Stars represent the aggregate review status, or the level of review supporting the aggregate germline classification for this VCV record. This value is calculated by NCBI based on data from submitters. Read our rules for calculating the review status. The number of submissions which contribute to this review status is shown in parentheses.

Uncertain significance

criteria provided, single submitter

Somatic

No data submitted for somatic clinical impact

Somatic

No data submitted for oncogenicity

Variant Details

Identifiers

NM_000501.4(ELN):c.1034_1087dup (p.Ala362_Ala363insGlyValProGlyAlaGlyIleProValValProGlyAlaGlyIleProGlyAla)

Variation ID: 2894197 Accession: VCV002894197.1

Type and length

Duplication, 54 bp

Location

Cytogenetic: 7q11.23 7: 74053244-74053245 (GRCh38) [ NCBI UCSC ] 7: 73467574-73467575 (GRCh37) [ NCBI UCSC ]

Timeline in ClinVar

	First in ClinVar Help The date this variant first appeared in ClinVar with each type of classification.	Last submission Help The date of the most recent submission for each type of classification for this variant.	Last evaluated Help The most recent date that a submitter evaluated this variant for each type of classification.
Germline	Feb 20, 2024	Feb 20, 2024	Feb 1, 2023

HGVS

Nucleotide	Protein	Molecular consequence
NM_000501.4:c.1034_1087dup MANE Select Help Transcripts from the Matched Annotation from the NCBI and EMBL-EBI (MANE) collaboration.	NP_000492.2:p.Ala362_Ala363insGlyValProGlyAlaGlyIleProValValProGlyAlaGlyIleProGlyAla	inframe insertion
NM_001081752.3:c.1004_1057dup	NP_001075221.1:p.Ala352_Ala353insGlyValProGlyAlaGlyIleProValValProGlyAlaGlyIleProGlyAla	inframe insertion
NM_001081753.3:c.1049_1102dup	NP_001075222.1:p.Ala367_Ala368insGlyValProGlyAlaGlyIleProValValProGlyAlaGlyIleProGlyAla	inframe insertion
NM_001081754.3:c.1049_1102dup	NP_001075223.1:p.Ala367_Ala368insGlyValProGlyAlaGlyIleProValValProGlyAlaGlyIleProGlyAla	inframe insertion
NM_001081755.3:c.1034_1087dup	NP_001075224.1:p.Ala362_Ala363insGlyValProGlyAlaGlyIleProValValProGlyAlaGlyIleProGlyAla	inframe insertion
NM_001278912.2:c.1034_1087dup	NP_001265841.1:p.Ala362_Ala363insGlyValProGlyAlaGlyIleProValValProGlyAlaGlyIleProGlyAla	inframe insertion
NM_001278913.2:c.926_979dup	NP_001265842.1:p.Ala326_Ala327insGlyValProGlyAlaGlyIleProValValProGlyAlaGlyIleProGlyAla	inframe insertion
NM_001278914.2:c.1019_1072dup	NP_001265843.1:p.Ala357_Ala358insGlyValProGlyAlaGlyIleProValValProGlyAlaGlyIleProGlyAla	inframe insertion
NM_001278915.2:c.1034_1087dup	NP_001265844.1:p.Ala362_Ala363insGlyValProGlyAlaGlyIleProValValProGlyAlaGlyIleProGlyAla	inframe insertion
NM_001278916.2:c.992_1045dup	NP_001265845.1:p.Ala348_Ala349insGlyValProGlyAlaGlyIleProValValProGlyAlaGlyIleProGlyAla	inframe insertion
NM_001278917.2:c.1004_1057dup	NP_001265846.1:p.Ala352_Ala353insGlyValProGlyAlaGlyIleProValValProGlyAlaGlyIleProGlyAla	inframe insertion
NM_001278918.2:c.902_955dup	NP_001265847.1:p.Ala318_Ala319insGlyValProGlyAlaGlyIleProValValProGlyAlaGlyIleProGlyAla	inframe insertion
NM_001278939.2:c.1034_1087dup	NP_001265868.1:p.Ala362_Ala363insGlyValProGlyAlaGlyIleProValValProGlyAlaGlyIleProGlyAla	inframe insertion
NC_000007.14:g.74053247_74053300dup
NC_000007.13:g.73467577_73467630dup
NG_009261.1:g.30151_30204dup

... more HGVS ... less HGVS

Protein change

Other names

Canonical SPDI

Functional consequence Help The effect of the variant on RNA or protein function, based on experimental evidence from submitters.

Global minor allele frequency (GMAF) Help The global minor allele frequency calculated by the 1000 Genomes Project. The minor allele at this location is indicated in parentheses and may be different from the allele represented by this VCV record.

Allele frequency Help The frequency of the allele represented by this VCV record.

Links

VarSome

Genes

Gene	OMIM	ClinGen Gene Dosage Sensitivity Curation		Variation Viewer Help Links to Variation Viewer, a genome browser to view variation data from NCBI databases.	Related variants
Gene	OMIM	HI score Help The haploinsufficiency score for the gene, curated by ClinGen’s Dosage Sensitivity Curation task team.	TS score Help The triplosensitivity score for the gene, curated by ClinGen’s Dosage Sensitivity Curation task team.		Within gene Help The number of variants in ClinVar that are contained within this gene, with a link to view the list of variants.	All Help The number of variants in ClinVar for this gene, including smaller variants within the gene and larger CNVs that overlap or fully contain the gene.
ELN		Sufficient evidence for dosage pathogenicity	No evidence available	GRCh38 GRCh37	840	1160

Conditions - Germline

Condition Help The condition for this variant-condition (RCV) record in ClinVar.	Classification Help The aggregate germline classification for this variant-condition (RCV) record in ClinVar. The number of submissions that contribute to this aggregate classification is shown in parentheses. (# of submissions)	Review status Help The aggregate review status for this variant-condition (RCV) record in ClinVar. This value is calculated by NCBI based on data from submitters. Read our rules for calculating the review status.	Last evaluated Help The most recent date that a submitter evaluated this variant for the condition.	Variation/condition record Help The RCV accession number, with most recent version number, for the variant-condition record, with a link to the RCV web page.
Supravalvar aortic stenosis	Uncertain significance (1)	criteria provided, single submitter	Feb 1, 2023	RCV003632566.2

Submissions - Germline

Classification Help The submitted germline classification for each SCV record. (Last evaluated)	Review status Help Stars represent the review status, or the level of review supporting the submitted (SCV) record. This value is calculated by NCBI based on data from the submitter. Read our rules for calculating the review status. This column also includes a link to the submitter’s assertion criteria if provided, and the collection method. (Assertion criteria)	Condition Help The condition for the classification, provided by the submitter for this submitted (SCV) record. This column also includes the affected status and allele origin of individuals observed with this variant.	Submitter Help The submitting organization for this submitted (SCV) record. This column also includes the SCV accession and version number, the date this SCV first appeared in ClinVar, and the date that this SCV was last updated in ClinVar.	More information Help This column includes more information supporting the classification, including citations, the comment on classification, and detailed evidence provided as observations of the variant by the submitter.
Uncertain significance (Feb 01, 2023)	criteria provided, single submitter (Invitae Variant Classification Sherloc (09022015)) Method: clinical testing	Supravalvar aortic stenosis Affected status: unknown Allele origin: germline	Labcorp Genetics (formerly Invitae), Labcorp Accession: SCV004520034.1 First in ClinVar: Feb 20, 2024 Last updated: Feb 20, 2024	Comment: In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant … (more) In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Experimental studies and prediction algorithms are not available or were not evaluated, and the functional significance of this variant is currently unknown. This variant has not been reported in the literature in individuals affected with ELN-related conditions. This variant is not present in population databases (gnomAD no frequency). This variant, c.1034_1087dup, results in the insertion of 18 amino acid(s) of the ELN protein (p.Gly345_Ala362dup), but otherwise preserves the integrity of the reading frame. (less)

Comment:

In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Experimental studies and prediction algorithms are not available or were not evaluated, and the functional significance of this variant is currently unknown. This variant has not been reported in the literature in individuals affected with ELN-related conditions. This variant is not present in population databases (gnomAD no frequency). This variant, c.1034_1087dup, results in the insertion of 18 amino acid(s) of the ELN protein (p.Gly345_Ala362dup), but otherwise preserves the integrity of the reading frame.

Germline Functional Evidence

There is no functional evidence in ClinVar for this variation. If you have generated functional data for this variation, please consider submitting that data to ClinVar.

Comment:

Citations for germline classification of this variant

There are no citations for germline classification of this variant in ClinVar. If you know of citations for this variation, please consider submitting that information to ClinVar.

Text-mined citations for this variant ...

Record last updated Sep 30, 2024

ClinVar Genomic variation as it relates to human health

NM_000501.4(ELN):c.1034_1087dup (p.Ala362_Ala363insGlyValProGlyAlaGlyIleProValValProGlyAlaGlyIleProGlyAla)

Variant Details

Genes

Conditions - Germline

Submissions - Germline

Germline Functional Evidence

Citations for germline classification of this variant

Text-mined citations for this variant ...